首页|黄莪胶囊治疗气滞血瘀型慢性前列腺炎/慢性盆腔疼痛综合征的疗效

黄莪胶囊治疗气滞血瘀型慢性前列腺炎/慢性盆腔疼痛综合征的疗效

扫码查看
目的 探讨黄莪胶囊治疗气滞血瘀型慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)的疗效和安全性.方法 选取2022年7月至2023年7月浙江中医药大学附属第二医院、浙江省荣军医院、湖州市中医院和宁波市中医院收治的120例气滞血瘀型CP/CPPS患者作为研究对象.随机分为研究组和对照组,每组60例,分别接受黄莪胶囊及α受体阻滞剂治疗.两组在基线(第0周,治疗前)、第4周、第8周(治疗结束)、第12周(延长随访)时完成美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)问卷(包括疼痛、排尿症状和生活质量3个亚项).比较两组基线、第4周、第8周、第12周NIH-CPSI各亚项评分及总分.比较两组第8周时NIH-CPSI应答情况及治疗期间不良事件发生情况.结果 第8周和第12周时,研究组NIH-CPSI疼痛亚项评分、生活质量亚项评分和总分均低于对照组(P<0.05).第8周时,研究组NIH-CPSI应答率高于对照组(P=0.027).与非应答组比较,应答组症状持续时间稍短,NIH-CPSI疼痛亚型、生活质量亚项评分和总分更高,差异具有统计学意义(P<0.05).研究组和对照组不良事件发生情况比较,差异无统计学意义(P>0.05).结论 CP/CPPS患者采用黄莪胶囊治疗,可在短期内显著改善疼痛症状和生活质量,并且在8周疗程结束后仍有一定的拖尾效应.
Efficacy of Huang'e Capsule in the treatment of chronic prostatitis/chronic pelvic pain syndrome of Qi-stagnation and blood-stasis syndrome
Objective To investigate the efficacy and safety of Huang'e Capsule in treating chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS)with Qi-stagnation and blood-stasis.Methods A total of 120 CP/CPPS patients with Qi-stagnation and blood-stasis admitted to Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Zhejiang Rongjun Hospital,Huzhou Traditional Chinese Medicine Hospital and Ningbo Traditional Chinese Medicine Hospital from July 2022 to July 2023 were selected as study objects.They were randomly divided into study group and control group,with 60 cases in each group.They were treated with Huang'e Capsule and α-blocker respectively.Both groups completed the national institutes of health chronic prostatitis symptoms index(NIH-CPSI)questionnaire(including three subitems with pain,urination symptoms,and quality of life)at baseline(0th week,before treatment),4th week,8th week(end of treatment),and 12th week(extended follow-up).The subitem scores and total scores of NIH-CPSI at baseline,4th week,8th week and 12th week were compared between two groups.The NIH-CPSI responses condition at 8th week and adverse events occurrence during treatment were compared between the two groups.Results At 8th week and 12th week,the NIH-CPSI pain subitem scores,quality of life subitem scores and total score of the study group were all lower than those of the control group(P<0.05).At 8th week,NIH-CPSI response rate in the study group was higher than that in the control group(P=0.027).Compared with the non-responding group,the symptom duration of the responding group was slightly shorter,and the NIH-CPSI pain subtype,quality of life subitem scores and total score were higher,with statistical significance differences(P<0.05).There was no significant difference in the occurrence of adverse events between study group and control group(P>0.05).Conclusions The treatment of CP/CPPS patients with Huang'e Capsule can significantly improve the pain symptoms and quality of life in the short term,and there is still a certain tailing effect after the end of the 8-week course.

Huang'e CapsuleChronic prostatitisChronic pelvic pain syndromeEfficacy

王恒资、陈刚、于田强、孙涛、杨浩、段跃

展开 >

浙江中医药大学附属第二医院泌尿外科,杭州 310005

浙江省荣军医院泌尿外科,浙江嘉兴 314000

宁波市中医院泌尿外科,浙江宁波 315010

湖州市中医院泌尿外科,浙江湖州 313099

展开 >

黄莪胶囊 慢性前列腺炎 慢性盆腔疼痛综合征 疗效

浙江省医学会临床科研基金项目

2022ZYC-Z04

2024

中国性科学
中国性学会

中国性科学

CSTPCD
影响因子:1.394
ISSN:1672-1993
年,卷(期):2024.33(6)
  • 6